Med-tech firms raising money in public or private financings, including: Pockethealth, Tempo Therapeutics, Ultrahuman.

Med-tech firms raising money in public or private financings, including: Genprex.

Med-tech deal value in February jumped to $255.61 million, an increase of 137.23% from the $107.75 million in deals from January, yet below the 2023 monthly average of $886.13 million. On the M&A front, med-tech transactions hit their lowest point since May 2019, totaling only $16 million.

Techbio specialist Relation Therapeutics Ltd has raised $35 million in new seed funding, bringing total seed money to $60 million, as it advances development of its in silico/wet lab platform for identifying drug targets in the non-coding parts of the genome. The company is building a “lab in the loop” system where in depth ‘omics profiles of single cells from fresh patient tissues are analyzed by its machine learning engine to uncover the genetic basis of clinical phenotypes and identify novel targets.

Med-tech firms raising money in public or private financings, including: Carlsmed, Delcath, Neupulse, Spineheart.

Med-tech firms raising money in public or private financings, including: Oxford Biodynamics, Thinksono.